Introduction {#cwy003s1}
============

A historical perspective on keratan sulfate {#cwy003s2}
-------------------------------------------

Keratan sulfate (KS) was first identified in the cornea by Suzuki and colleagues in 1939 ([@cwy003C306]), it was identified as a mucoid type material containing galactose and glucose in equimolar amounts, and also acetyl and sulfate groups. Karl Meyer and colleagues subsequently characterized this mucinous mucopolysaccharide in a series of studies renaming it kerato-sulfate ([@cwy003C211], [@cwy003C210]; [@cwy003C69]; [@cwy003C141], [@cwy003C142]; [@cwy003C285]; [@cwy003C28], [@cwy003C29]; [@cwy003C35]; [@cwy003C290]; [@cwy003C58]; [@cwy003C167]; [@cwy003C212]). Ongoing studies on the characterization of KS and KS-proteoglycans established the current name of this mucopolysaccharide as keratan sulfate. Investigations on the kerato-sulfates were initially compositional studies, and structural analyses on the linkage region of kerato-sulfate to protein ([@cwy003C35]; [@cwy003C29]; [@cwy003C58]; [@cwy003C39]). Most work was initially conducted on corneal KS and this was subsequently classified as KS-I but despite this naming KS-I is also found in tissues other than cornea as a side chain components of members of the SLRP family members keratocan, fibromodulin and lumican ([@cwy003C252], [@cwy003C253]; [@cwy003C182]). Comparative studies on corneal KS and the KS of cartilaginous tissues in a number of species subsequently identified a different *O*-linkage group to protein through serine or threonine residues and variable levels of [l]{.smallcaps}-fucose and *N*-acetylneuraminic acid capping residues ([@cwy003C58]). Thus skeletal KS was subsequently classified as KS-II to distinguish it from corneal KS-I. Ongoing studies on KS in brain tissues, the next richest source of KS in the human body after the cornea, identified a further *O*-linkage region through *D*-mannose residues in KS and this was classified as KS-III ([@cwy003C174]) (Figure [1](#cwy003F1){ref-type="fig"}). Although variations in chain length and sulfation patterns and differences in the types of linkage groups were noted all three forms of KS were found to share common structural elements including stretches of non-sulfated poly-*N*-acetyllactosamine, and variable regions of mono- and disulfated regions of 6-sulfated [d]{.smallcaps}-galactose and *N*-acetylglucosamine, the two glycosaminoglycans of the characteristic repeat disaccharide unit of KS. The variable presence of minor [l]{.smallcaps}-fucose and *N*-acetylneuraminic acid further distinguished KS-I, II, III. While these residues conferred resistance to the KS chain to degradation by keratanase-I, II and endo-β-[d]{.smallcaps}-galactosidase (Figure [2](#cwy003F2){ref-type="fig"}) the full significance of these glycan components on the interactive properties of KS are only now beginning to be uncovered. Up till now, most GAG interactive studies have been conducted using the CS-A, CS-B, CS-D, CS-E isomers and HS and there is a massive literature published on these GAGs. However, a few studies have now shown that KS also has interactive properties with a number of regulatory proteins. Surface plasmon resonance studies have shown that corneal KS interacts with SHH, FGF1 and FGF2 ([@cwy003C337]). The core proteins of the KS-SLRPs are also highly interactive proteins due to their LRR motifs.

![Structural complexity of KS. Corneal KS-I, skeletal KS-II, i antigen, I antigen.](cwy003f01){#cwy003F1}

![The cleavage sites of keratanase-I, keratanase II and endo-β-[d]{.smallcaps}-galactosidase on a typical KS-I chain. For information on the KS-oligosaccharides released, see [@cwy003C41], [@cwy003C42]) and [@cwy003C312], [@cwy003C313]).](cwy003f02){#cwy003F2}

A recent study with corneal KS using a proteomics screen with a microarray of 8268 proteins and custom array of 85 extracellular nerve growth factor protein epitopes has uncovered a wealth of data pointing to potential roles for KS in cell-signaling processes in neural tissues ([@cwy003C60]). Highly sulfated KS interacted with 217 of the microarray proteins examined including 75 kinases, several membrane and secreted proteins, cytoskeletal proteins and a number of nerve regulatory proteins. These interactions were confirmed using plasmon resonance and binding constants determined. Of the 85 ECM nerve-related epitopes examined, KS bound to almost half of these, including Slit, two Robo's, nine ephrin receptors, eight ephrins, eight semaphorins and two nerve growth factor receptors. The SLIT-ROBO cell-signaling pathway has important roles to play in axonal guidance and neural angiogenic processes ([@cwy003C317]; [@cwy003C23]; [@cwy003C223]). Slit is a secreted protein which provides a repulsive cue for the directional guidance of axons during neuronal development and repair processes ([@cwy003C264]), Robo is its transmembrane protein cellular receptor. Vertebrates contain four Robo receptors and three Slits ([@cwy003C349]). Slits are modular proteins containing many LRRs, 7--9 EGF repeat modules and an **A**grin, **L**aminin, **P**erlecan, **S**lit (ALPS) interactive domain ([@cwy003C145]; [@cwy003C147]). These LRRs and EGFs have well-known functional interactive properties with proteins. Robos are transmembrane receptors which contain five IgG-like domains, three fibronectin type III repeats and an intracellular cytoplasmic domain containing up to four conserved CCO, CC1, CC2 and CC3 motifs containing potential sites of tyrosine phosphorylation, netrin-1 binding activity and binding sites for Ena/Vasp proteins ([@cwy003C300]). Ena/Vasp homology proteins are a family of closely related proteins involved in cellular motility through regulatory properties exerted on the spatial polymerization of actin structures required to promote chemotaxis in response to attractive and repulsive cues ([@cwy003C340]). Interactions of KS with Robo-Slit results in downstream activation of Rho GTPases which mediate actin depolymerization, cytoskeletal re-organization and cell signaling. Ephrins are a family of protein ligands for the Ephrin receptors. This is the largest subfamily of receptor protein--tyrosine kinases. These are membrane-bound proteins, which regulate intracellular signaling pathways arising from direct cell--cell interaction. Semaphorins are secreted and membrane-bound axonal growth cone guidance proteins which act as short-range inhibitory signals through multimeric plexin and neuropilin receptors to regulate Rho family GTPases and are critical to axonal guidance in neural development and repair processes. KS research is therefore entering an exciting era. Functional studies on KS in neural tissues are eagerly anticipated and may yield information of application in neural repair biology.

Tissue distribution of KS, KS--proteoglycans and KS--glycoproteins in tissues {#cwy003s3}
-----------------------------------------------------------------------------

KS (Figures [1](#cwy003F1){ref-type="fig"} and [2](#cwy003F2){ref-type="fig"}) is a widely distributed glycosaminoglycan (GAG) in tensional and weight-bearing connective tissues (cornea, bone, cartilage, intervertebral disc, tendon), epithelial tissues and the central and peripheral nervous system (CNS/PNS) ([@cwy003C106], [@cwy003C107]). KS is attached to a number of proteoglycan and glycoprotein core proteins (Table [I](#cwy003TB2){ref-type="table"}). KS--proteoglycans (KSPGs) display adaptable and variable functional interactive properties in situ and are localized within tissues in a specific spatio-temporal manner with important roles in tissue morphogenesis. Like all GAGs the variable but specific sulfation status of KS is an important functional determinant encoding a significant level of information which cells can interpret to influence cellular metabolism and behavior to effect tissue homeostasis, modulation of tissue structure and the assembly of key extracellular matrix (ECM) assemblies in tissue morphogenesis critical in the determination of tissue form and function. The ability to perceive ion-fluxes by KS is a conduit to the sensory capability of cells which allows them to perceive and respond dynamically to biomechanical changes in their microenvironment equipping them with the ability to modulate the synthesis and assembly of ECM components to form a matrix which better protects them from extrinsic forces. In some cells, the ability to sense and control ion-fluxes is highly advanced such as in neurons which generate action potentials ([@cwy003C46]), the basis of synaptic function that has even been proposed as a mechanism whereby cognitive memory is generated ([@cwy003C80]). Synaptic vesicle protein-2 (SV2) is a transport proteoglycan for neurotransmitters ([@cwy003C17]; [@cwy003C89]; [@cwy003C282]; [@cwy003C50]; [@cwy003C231]; [@cwy003C332]). Glial cells (oligodendrocytes, astrocytes, Schwann cells) produce KSPGs and KS-substituted glycoproteins ([@cwy003C103]; [@cwy003C120]; [@cwy003C119]; [@cwy003C44]; [@cwy003C260]; [@cwy003C158]; [@cwy003C212]; [@cwy003C157]; [@cwy003C246]; [@cwy003C75]; [@cwy003C329]; [@cwy003C291]; [@cwy003C328]), with roles in the demarcation of functional areas of the PNS/CNS and assembly of the myelin sheath encompassing neurons (Table [I](#cwy003TB2){ref-type="table"}). KS has associated Ca2+ counterions which may act as a calcium reserve for egg shell production ([@cwy003C127]; [@cwy003C77]) and in the mineralization of bone in laying birds and in the generation of action potentials in neurons. KS-substituted small leucine repeat proteoglycans (SLRPs) also have roles in bone formation ([@cwy003C168]; [@cwy003C297]; [@cwy003C335]; [@cwy003C122]; [@cwy003C219]; [@cwy003C148]; [@cwy003C228]).

The biodiversity of KSPGs {#cwy003s4}
-------------------------

KSPGs are widely distributed and display a diverse range of functional properties (Table [I](#cwy003TB2){ref-type="table"}). In tissues, KS chains can be either *N-* or *O*-linked to the proteoglycan core protein.

###### 

KS antibodies and the epitopes they identify illustrate KS structural complexity

  Antibody        Epitope identified                                                                                                                                                                                                                                                                                                              Reference
  --------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------
  EMCA-2, 3¶      Mucin core antigens, mucin-like polylactosamine                                                                                                                                                                                                                                                                                 [@cwy003C13], [@cwy003C74]
  TRA-1-60        Epitope sensitive to neuraminidase, keratanase-I, II and endo-β-[d]{.smallcaps}-galactosidase. terminal type 1 lactosamine: Galβ1--3GlcNAcβ1--3Galβ1--4GlcNAc and Galβ1--3GlcNAcβ1--3Galβ1--4GlcNAcβ1--6 (Galβ1--3GlcNAcβ1--3)Galβ1--4Glc oligosaccharide, expressed on podocalyxcin                                            [@cwy003C1], [@cwy003C9], [@cwy003C14], [@cwy003C222], [@cwy003C278]
  TRA-1-81        Epitope is resistant to neuraminidase but sensitive to endo-β-[d]{.smallcaps}-galactosidase, keratanase-I, II. Epitope is a terminal type 1 lactosamine: Galβ1--3GlcNAcβ1--3Galβ1--4GlcNAc and Galβ1--3GlcNAcβ1--3Galβ1--4GlcNAcβ1--6(Galβ1--3GlcNAcβ1--3)Galβ1--4Glc oligosaccharide, expressed on cell surface podocalyxcin   [@cwy003C1], [@cwy003C9], [@cwy003C14], [@cwy003C222], [@cwy003C278]
  R-10G           Low sulfation KS expressed on cell surface podocalyxcin on pluripotent embryonic stem cells                                                                                                                                                                                                                                     [@cwy003C161], [@cwy003C198], [@cwy003C221]
  SSEA-1¶         Cell surface glycan of murine embryonic pluripotent stem cells, epitope expressed on proteoglycan and glycoprotein core proteins and bioactive lipids                                                                                                                                                                           [@cwy003C245]
  "i" antigen¶    Human autoantibody to non-branched epitope in non-sulfated poly-*N*-acetyllactosamine (see Figure [1](#cwy003F1){ref-type="fig"})                                                                                                                                                                                               [@cwy003C91], [@cwy003C92], [@cwy003C93], [@cwy003C347], [@cwy003C348]
  "I" antigen¶    Human autoantibody to branched epitope in non-sulfated poly-*N*-acetyllactosamine (see Figure [1](#cwy003F1){ref-type="fig"})                                                                                                                                                                                                   [@cwy003C91], [@cwy003C92], [@cwy003C93], [@cwy003C347], [@cwy003C348]
  4C4             Highly sulfated KS on podocalyxcin in embryonic tumor cells                                                                                                                                                                                                                                                                     [@cwy003C104]
  5D4             Hexa sulfated KS octa-saccharide and a linear dodecasaccharide containing *N-*sulfated glucosamine                                                                                                                                                                                                                              [@cwy003C52], [@cwy003C202]
  MZ15            Hepta and octa-saccharide KS oligosaccharides                                                                                                                                                                                                                                                                                   [@cwy003C202]
  1B4             Tetrasulfated hexasaccharide in linear KS                                                                                                                                                                                                                                                                                       [@cwy003C202]
  4D1             Sulfated linear poly-*N*-acetyllactosamine epitope                                                                                                                                                                                                                                                                              B. Kerr PhD Thesis, University of Cardiff (2005).
  2D3             Highly sulfated linear poly-*N*-acetyllactosamine epitope                                                                                                                                                                                                                                                                       
  3D12/H7         Trisulfated fucosylated poly-*N*-acetyllactosamine linkage region KS chains interspersed in the CS1 and 2 region of aggrecan (see Figure [1](#cwy003F1){ref-type="fig"})                                                                                                                                                        [@cwy003C94]
  D9B1            A sialo-KS epitope on endometrial KSPGs                                                                                                                                                                                                                                                                                         [@cwy003C13], [@cwy003C139], [@cwy003C293]
  6D2/B5          Fucosyl-KS epitope also detects fucoidan                                                                                                                                                                                                                                                                                        [@cwy003C18]
  SV1, SV2, SV4   High sulfation KS chains in SV2 proteoglycan                                                                                                                                                                                                                                                                                    [@cwy003C282], [@cwy003C291]
  EFG-11          Tri-KS disaccharides                                                                                                                                                                                                                                                                                                            [@cwy003C246]
  122             Highly sulfated KS                                                                                                                                                                                                                                                                                                              [@cwy003C246]
  1/14/16H9       Specific equine KS antibody                                                                                                                                                                                                                                                                                                     [@cwy003C234], [@cwy003C235]
  LC8.13          Lesser reactivity following keratanase pretreatment                                                                                                                                                                                                                                                                             [@cwy003C162]
  F1.2            Conformation dependent KS epitope on aggrecan core protein, un-reactive with KS-peptides released into media                                                                                                                                                                                                                    [@cwy003C162]
  BKS-1(+)        Keratanase-generated KS stub neoepitope                                                                                                                                                                                                                                                                                         [@cwy003C5]

EMCA, epithelial mucin core antigen; TRA, Trafalgar antigen, some authors also refer to this as tumor rejection antigen; SSEA. Stage specific embryonic antigen; ¶ these antibodies identify non-sulfated epitopes thus by definition these are not KS epitopes but poly-*N*-acetyllactosamine stretches occurring in KS.

Several members of the small leucine repeat proteoglycan (SLRP) family (fibromodulin, lumican, keratocan, mimecan, osteoadherin) contain small N-linked KS chains (Figure [3](#cwy003F3){ref-type="fig"}A--F). The SLRPs contain leucine rich repeat regions (LRRs) that provide interactive properties with ECM proteins (Figure [3](#cwy003F3){ref-type="fig"}A--F). The SLRPs regulate collagen fibrillogenesis, and interact with cytokines and growth factors which regulate cell proliferation, cell signaling and matrix assembly ([@cwy003C140]; [@cwy003C209]; [@cwy003C71]; [@cwy003C55]; [@cwy003C56]). Some SLRP members (PRELP, mimecan, osteoadherin) have small minimally sulfated KS chains and roles in the laying down of bone, cellular adhesion and anchorage of the basement membrane to adjacent connective tissue ([@cwy003C25], [@cwy003C24]; [@cwy003C297]; [@cwy003C156]).

![Structural diagrams of some selected extracellular matrix KS-proteoglycans. Fibromodulin (**A**), lumican (**B**), PRELP (**C**), Osteoadherin (**D**), keratocan (**E**) and mimecan/osteoglycin (**F**). These are horseshoe-shaped members of the small leucine rich repeat proteoglycan (SLRP) family. Aggrecan (**G**) is a member of the lectican proteoglycan family. KS chains in aggrecan occur in five regions indicated in the boxed areas in (**G**). These are (1) the G1 hyaluronan binding region (HABR), (2) interglobular domain (IGD), (3) G2 globular domain, (4) KS-rich region. (5) KS chains are also interspersed throughout the CS1 and CS2 domains of the CS-rich region.](cwy003f03){#cwy003F3}

Aggrecan is a large KS and CS substituted proteoglycan of the lectican family which has important space filling and water imbibing properties in cartilaginous tissues ([@cwy003C165]) (Figure [3](#cwy003F3){ref-type="fig"}G). Aggrecan in cartilage forms massive macro-aggregate link protein-stabilized ternary structures with hyaluronan which have impressive water trapping properties within tissues providing the tissue with a resistance to compression ([@cwy003C267]). Aggrecan is widely distributed in articular, hyaline, elastic and fibrocartilages in diarthrodial joints, rib, nasal and tracheal cartilages as well as the larynx, outer ear and epiglottis ([@cwy003C265], [@cwy003C266]). Aggrecan equips these tissues with the ability to withstand compression and provides mechanical support to the elastic or collagenous fibers that convey and control reversible tissue deformability or the ability to withstand tensional forces as well as providing strong interconnections between muscle and bone. In adult cartilage, aggrecan contains \~100 CS and \~25--50 KS chains which collectively represent \~90% of the mass of this molecule ([@cwy003C165]). KS is localized in a region adjacent to the CS rich region in all species examined except rodent aggrecan which has a truncated core protein devoid of a KS-rich region ([@cwy003C21]). Small KS chains are also found in the G1 and G2 globular domains of aggrecan and in the interglobular domain (IGD) between G1 and G2 regions ([@cwy003C20], [@cwy003C22]; [@cwy003C100]). The role of the KS chains within the KS-rich region is not known; however, the other KS chains located towards the N-terminus of aggrecan have roles in the suppression of a T cell-mediated response to free G1 when used as an arthritogen ([@cwy003C185]; [@cwy003C121]; [@cwy003C125]) and also regulate aggrecanolysis by aggrecanases ([@cwy003C254]). Although not formally considered a KSPG, versican G1 domains also contains KS chains whose roles await determination ([@cwy003C308]).

KSPGs and KS-substituted glycoproteins have been identified in epithelial tissues. MUC1 is a widely distributed mucin glycoprotein that contains small minimally sulfated KS chains. Podocalyxcin is a 240 kDa sialylated mucin-like cell membrane proteoglycan, which contains small low sulfation KS chains in embryonic and highly sulfated KS chains in adult tissues (Figure [4](#cwy003F4){ref-type="fig"}A). Endometrial KSPG and PZP-3 have roles in fertilization and implantation. Variants of CD44 and perlecan have also been described bearing KS chains, the role of these KS chains remains to be established; however, it is likely that they may modulate growth factor binding and matrix organization.

![Schematic depictions of cell-associated KS-proteoglycans. Podocalyxcin (**A**). Protein Tyrosine Phosphatase Receptor-β/ζ/Phosphacan (**B**) and synapse vesicle proteoglycan-2 (SV-2) (**C**). The podocalyxcin core protein is heavily substituted with *N*- and *O*-linked oligosaccharides and these are potential linkage sites for KS. Phosphacan is the ecto-domain of the transmembrane Protein Tyrosine Phosphatase Receptor-β/ζ which contains KS, CS and HNK-1 trisaccharide GAG substitution. SV-2 is a 12 span transmembrane KS--proteoglycan with transport functions for neurotransmitters in synaptic vesicles and occurs as low (100 kDa) and high (250 kDa) molecular weight forms containing KS substitution on three N-linked glycosylation sites at amino acids 498, 548 and 573. The free core protein of SV-2 is 80 kDa. SV2 occurs as three alternatively spliced isoforms SV2A, B, C of variable tissue distribution in the CNS/PNS.](cwy003f04){#cwy003F4}

After the cornea, the brain is the next richest source of KS in the human body and contains a number of large KSPGs, which contain highly sulfated KS-III chains. Abakan is synthesized by astrocytes, directs neuritogenesis and defines the functional boundaries of areas of the brain. Claustrin has anti-adhesive properties and also directs axonal growth and repair. Phosphacan is one of the most abundant KSPGs in brain tissue and has roles in the regulation of neuronal development and repair processes (Figure [4](#cwy003F4){ref-type="fig"}B). PG1000 is a large KSPG detected in the electric organ and may have roles in synaptic assembly processes and neurotransmission. Synaptic protein-2 (SV2) is a 12 span proteoglycan with novel transport properties (Figure [4](#cwy003F4){ref-type="fig"}C). SV-2 contains three large highly sulfated KS chains that interact with neurotransmitters in a smart gel complex within the synaptic vesicle which functions in neurotransmitter storage and transmission.

Embryoglycan is a highly branched mucin-like sialylated cell surface glycoprotein of embryonic pluripotent stem cells that contains a number of developmentally regulated carbohydrate motifs and small non-sulfated poly-*N*-acetyllactosamine residues similar to in corneal KS (Figure [5](#cwy003F5){ref-type="fig"}).

![Schematic representation of the structural organization of embryoglycan, a cell membrane associated KS--proteoglycan of pluripotent embryonic stem cells.](cwy003f05){#cwy003F5}

Besides its well-documented roles in cartilaginous tissues, aggrecan also has roles in the development of heart tissue and in the valve leaflets ([@cwy003C351]; [@cwy003C190]) and in perineural net formation in the cortex, hippocampus, thalamus, brain stem and spinal cord ([@cwy003C327]). Perineural nets are macroaggregates assembled from HA, link protein and tenascin-R which surround and protect neuron dendritic synaptic contact areas ([@cwy003C19]; [@cwy003C248]; [@cwy003C327]). Another KSPG, SV2 has roles in the development and function of electro-conductive tissue in the heart and PNS/CNS. SV2 occurs as a low and a high molecular weight form which reflects the relative size of the KS chain on each form (Figure [6](#cwy003F6){ref-type="fig"}A and B). SV2A expression is down-regulated and SV2C up-regulated in epileptic foci in humans with intractable temporal lobe epilepsy ([@cwy003C66]). SV2 knockout mice lacking SV2A display abnormal neurotransmission and epileptic seizures ([@cwy003C67]; [@cwy003C318]). Preclinical and clinical targeting of SV2A with the anti-convulsant drug leveritacetam in humans and in laboratory studies in SV2A deficient mice demonstrate the important roles SV2 plays in normal brain function ([@cwy003C195]; [@cwy003C227]; [@cwy003C199]). SV2 acts as a calcium reservoir; Ca2+ has roles in the generation of synaptic action potentials. SV2 also has transport properties for neurotransmitters into synaptic vesicles and acts as a smart gel delivery system important for neuron functional properties (Figure [6](#cwy003F6){ref-type="fig"}C). Mammallin is another KS--proteoglycan which act as a Ca2+ reservoir in egg shell assembly. A KS--glycoprotein in medullary bone, bone sialoprotein-II (BSP-II) is synthesized in synchrony with the egg laying cycle in egg laying birds. ([@cwy003C129]). Bone sialoprotein-II (BSP-II) from compact rabbit bone is a KSPG; however, some studies have shown that BSP-II from other species may not contain KS ([@cwy003C200]; [@cwy003C168]; [@cwy003C113]; [@cwy003C129]). KS chains have also been detected on transferrin and thyroglobulin in papillary thyroid carcinoma where the KS chains may be of diagnostic value and on keratin filaments produced by keratinocytes but the roles of these KS chains are unknown.

![Schematic representation of the functional organization of SV-2 proteoglycan of synaptic vesicles, low (100 kDa) and high (250 kDa) molecular weight forms are depicted in (**A**) and (**B**). The KS chains (orange) of SV2 distributed around a synaptic vesicle (green dotted line) interact with Ca^2^+ and neurotransmitters such as dopamine as illustrated in the central green highlighted region in a smart gel proteoglycan delivery complex (**C**).](cwy003f06){#cwy003F6}

Functional properties of KSPGs {#cwy003s5}
------------------------------

KS occurs on proteoglycans in connective tissues that contain chondroitin sulfate (CS) and both of these GAGs influence tissue hydration and organization; however, some KS-specific functional properties have also been demonstrated. Mouse macrophages express a high-affinity cell surface receptor for the KSPG lumican; these receptors are modified with mono-sulfated oligolactosamine. These cells do not bind lumican that carries sulfated KS chains, nor will they attach and spread on plastic surfaces coated with KS-substituted lumican. Removal of KS with endo-β-galactosidase restores attachment and spreading of these cells in vitro indicating that low sulfation KS is involved in this process ([@cwy003C111]). Human melanoma A375 cells grown on lumican coated culture surfaces undergo morphological changes apparently due to rearrangement in their actin cytoskeletons which may underly the inhibitory effect lumican displays on the migration of melanoma cells ([@cwy003C258]). A 17 amino acid peptide derived from LRR-9 of lumican has been isolated (lumcorin), and shown to decrease melanoma progression ([@cwy003C352]; [@cwy003C251]). This anti-tumor activity resides in the ability of lumcorin to inhibit cell motility by inhibition of focal adhesion kinase phosphorylation and by blocking melanoma cell interactions with α2β1 integrin preventing the development of focal adhesion complexes which are required for cell migration. Lumican also exerts angiostatic properties on endothelial cells which provides tumor inhibitory activity in melanoma and a number of other tumors ([@cwy003C38]). Furthermore, lumican inhibits the expression and activation of MMP-9 and 14 ([@cwy003C251]) which also contributes to its anti-angiogenic/anti-tumor activity.

Anti-adhesive properties for KS have been observed in a number of studies. KSPGs constitute a barrier to neurite outgrowth in vitro and directs axon growth patterns during development and regeneration in vivo ([@cwy003C44]; [@cwy003C240]). This "barrier" function of KS is also evident in the KS chains of aggrecan G1 domains which block development of a T cell-mediated immune response in vivo and in vitro to the G1 domain when it is used as an arthritogen, suppressing development of antigen-induced osteoarthritis ([@cwy003C125]) ([@cwy003C185]). The KS content of endometrial uterine lining tissues varies markedly during the menstrual cycle, reaching a peak at the time of embryo implantation ([@cwy003C123]). KS substitution on MUC1 and other PGs in the endometrial lining suggests a potential regulatory role for KS in this implantation process ([@cwy003C12]; [@cwy003C13]; [@cwy003C72]; [@cwy003C59]). A number of KSPGs have been identified in endometrial tissue ([@cwy003C72]) with apparent roles in tissue organization and implantation. Zona pellucida glycoprotein-3 (PZP-3) contains low sulfation N-linked poly-*N*-acetyllactosamine residues which promote oocyte--sperm interactions and regulate fertilization ([@cwy003C230]; [@cwy003C344]; [@cwy003C126]; [@cwy003C220]). The KS chains within the IGD of aggrecan are smaller and of lower charge density than the *O*-linked KS chains in the KS-rich region and have critical roles to play in the aggrecanolysis process by aggrecanases ([@cwy003C254]) (Figure [3](#cwy003F3){ref-type="fig"}G). The basement membrane anchoring molecule PRELP also contains small low sulfation KS chains; however, their functional roles have yet to be determined ([@cwy003C25]).

Mimecan/osteoglycin, osteoadherin and keratocan are KSPGs with proposed roles in the laying down of bone ([@cwy003C108]; [@cwy003C297]; [@cwy003C335]; [@cwy003C316]; [@cwy003C148]; [@cwy003C228]). Keratocan is expressed by osteoblasts and can modulate osteoblast differentiation ([@cwy003C148]). Specific KSPGs (e.g. phosphacan) have also been demonstrated in the CNS/PNS which contain highly charged KS chains and which depending on cellular context can display anti-adhesive properties on neural cells for tenascin-C and laminin which promote neuronal/axonal repair processes ([@cwy003C117], [@cwy003C116]; [@cwy003C75]; [@cwy003C45]; [@cwy003C88]). Other brain KSPGs (Abakan, PG1000, SV2) contain highly charged KS chains which confer interactive properties in neurotransmission, brain ECM and synaptic organization and function.

KS is interactive with a number of cell stimulatory molecules which have important roles to play in skeletogenesis and in the regulation of tissue homeostasis ([@cwy003C242]). KS chains bind the cardiotoxins CTX A3 and T ([@cwy003C330]) and insulin-like growth factor binding protein-2 (IGFBP2) ([@cwy003C269]). Surface plasmon resonance has shown that corneal KS interacts with SHH, FGF1 and FGF2 ([@cwy003C337]). The core proteins of the KS-SLRPs are also highly interactive due to their LRRs. Fibromodulin and lumican bind to collagen and regulate fibrillogenesis, with fibromodulin promoting the formation of thick fibers while lumican promotes the formation of thin collagen fibers. Fibromodulin also binds to TGF-β and controls its bioavailability ([@cwy003C137]). The core proteins of keratocan and lumican interact with inflammatory cytokines such as CXCL1 ([@cwy003C49]). Lumican interacts with CD14 and activates the TLR-4 pattern recognition receptor as part of the innate immune response promoting phagocytosis of invading bacteria ([@cwy003C341]; [@cwy003C289]).

Mimecan/osteoglycin interacts with TGF-βs and BMPs ([@cwy003C151]), binding of mimecan to BMP2 and BMP3 provides osteoinductive activity ([@cwy003C26]). Mimecan acts as a carrier molecule releasing TGFβ and BMPs into the ECM during tissue development ([@cwy003C151]). TGF-βs enhance chondrocyte proliferation in early differentiation, but inhibit chondrocytes in their terminal differentiation stage prior to bone formation ([@cwy003C353]). Co-ordination of BMP2 and BMP3 with TGF-β2 activity potentiates cartilage and bone formation ([@cwy003C287]; [@cwy003C331]).

### Interactive Properties of KS {#cwy003s6}

GAGs interact with proteins in many different ways. Clusters of basic amino acids have been proposed as consensus GAG binding sites ([@cwy003C48]) while in other cases, interactions between GAGs and proteins appear to be purely charge-mediated ([@cwy003C268]) influenced by charge density due to the proximity of multiple GAG chains on PGs ([@cwy003C239]). A microarray analysis has shown that corneal KS interacts with a number of kinases, membrane and secreted proteins, cytoskeletal components and a number of nerve receptors and effector molecules ([@cwy003C60]). Plasmon resonance studies confirmed these interactions and binding constants were determined. KS interacts with a number of proteins of the Slit-Robo cell-signaling pathway which have roles in axonal guidance. Slits contain variable numbers of LRRs and 7--9 epidermal growth factor (EGF) repeats which are highly interactive modules with KS resulting in downstream activation of Rho GTPases which mediate actin depolymerization, cytoskeletal re-organization and cell signaling. KS is interactive with Ephrins and Ephrin receptors, the largest subfamily of receptor protein--tyrosine kinases. These are membrane-bound proteins, which regulate intracellular signaling pathways arising from direct cell--cell interaction resulting in the activation of Rho family GTPases critical to axonal guidance in neural development and repair processes.

KS structure {#cwy003s7}
------------

KS is composed of the basic repeating disaccharide [d]{.smallcaps}-galactose β1--4 linked to GlcNAc-6-sulfate. The poly-*N*-acetyllactosamine structure of KS is also found in glycoproteins of the *N*- and *O*-linkage families of mucin type glycoproteins and these can also bear KS chains in specific tissue contexts ([@cwy003C61]; [@cwy003C36]; [@cwy003C160]). Some cell surface KSPGs also have mucin type and other developmental carbohydrate structures ([@cwy003C241]; [@cwy003C279]; [@cwy003C259]; [@cwy003C278]; [@cwy003C124]). Three forms of KS have been identified on the basis of linkage type to PG core proteins, and the structural organization of their constituent saccharides. KS type I is attached to PG core proteins via an *N*-glycan linkage to asparagine via a high mannose type oligosaccharide, KS type II is an *O-*linked-glycan attached to threonine or serine residues via a mucin type structure on the core protein. A further KS type (type III) has been identified in the PNS/CNS attached via an *O*-linked 2-*O* mannose residue to serine residues on proteoglycan core proteins but is antigenically distinct from KS-I and KS-II ([@cwy003C107]) (Figure [1](#cwy003F1){ref-type="fig"}). A related mucin-like polylactosamine molecule, embryoglycan, has also been described which bears some similarities to minimally sulfated embryonic KS chains but is a highly branched molecule whereas KS-I is a linear molecule ([@cwy003C216]).

In mature tissues, the poly-*N*-acetyllactosamine region of KS-I can contain \~50 disaccharides and reach 20--25 kDa in size and consist of a mixture of non-sulfated, mono-sulfated (Gal-GlcNAc6S), and disulfated (Gal6S-GlcNAc6S) disaccharide units (Figure [1](#cwy003F1){ref-type="fig"}). Skeletal KS-II chains also contain capping [l]{.smallcaps}-fucose and *N*-acetylneuraminic acid residues to variable degree however this appears to vary within different tissues and these confer KS with resistant properties to digestion by keratanases and endo-β-[d]{.smallcaps}-galactosidase (Figure [2](#cwy003F2){ref-type="fig"}). Several members of the SLRP family contain small N-linked KS chains distributed in their central LRR regions. PRELP contains several small low sulfation KS chains however their functional roles have yet to be defined ([@cwy003C156]) (Figure [3](#cwy003F3){ref-type="fig"}A--F). The KS chains of aggrecan from weight-bearing tissues such as articular cartilage and IVD contain 1--3 fucose and 2--6 *N*-acetyl-neuraminic acid residues ([@cwy003C110], [@cwy003C109]; [@cwy003C165]); however, these are absent in aggrecan from non-weight-bearing nasal and tracheal cartilages ([@cwy003C224]). Aggrecan also contains a number of small *N*- and *O*-linked KS chains in the G1 and G2 domains and within the IGD of lower sulfation to the KS chains in the KS-rich region of the core protein (Figure [3](#cwy003F3){ref-type="fig"}G). Occasional proteins such as the cytokeratins and transferrin/thyroglobulin can also be decorated with KS chains in specific developmental contexts and these may be of value as biomarkers of the tissue pathology status (Table [I](#cwy003TB2){ref-type="table"}).

###### 

The biodiverse structural forms and functions of KS proteoglycans

  Protein                                                                    Distribution                                                                                 Functions                                                                                                                                                                                Reference
  -------------------------------------------------------------------------- -------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------
  **KS--proteoglycans of tensional and weight-bearing connective tissues**                                                                                                                                                                                                                                                                                         
  Aggrecan lectican KS/CSPG                                                  Large ECM PG of cartilage, CNS, tendon, IVD                                                  Tissue hydration, weight bearing. Inhibits neurite outgrowth, repulsive cue on axonal guidance                                                                                           [@cwy003C103], [@cwy003C165]
  Fibromodulin                                                               Widespread ECM distribution in cornea, cartilage, tendon, IVD, meniscus                      Regulate collagen fibrillogenesis and inflammatory cytokines/growth factors, cell proliferation and cell signaling. Lumican is a tumor marker                                            [@cwy003C55], [@cwy003C209], [@cwy003C274]
  Keratocan                                                                                                                                                                                                                                                                                                                                                        [@cwy003C30], [@cwy003C64], [@cwy003C238], [@cwy003C297]
  Lumican                                                                                                                                                                                                                                                                                                                                                          
  Osteoadherin (osteomodulin)                                                Cartilage/bone growth plate interface                                                        Cell binding bone KSPG, may regulate mineralization                                                                                                                                      [@cwy003C297]
  Mimecan (osteoglycin)                                                      Broad distribution in connective tissues                                                     Corneal mimecan is sulfated but not sulfated in other tissues. Has roles in bone induction                                                                                               [@cwy003C63], [@cwy003C108]
  CD44                                                                       Epidermal/CNS KS-CD44 isoform                                                                Ubiquitous HA receptor occurring as alternatively spliced forms substituted with KS, CS or HS                                                                                            [@cwy003C314]
  Bone sialoprotein-II (BSP-II)                                              80 kDa core protein, substituted with sialic acid and *N*- and *O*-linked KS chains          BSP-II, KSPG in compact rabbit bone, BSP-II from other species does not contain KS. Related KSPG identified in rat calvaria BSP-II in medullary bone in laying birds is a KSPG           [@cwy003C113], [@cwy003C129], [@cwy003C168], [@cwy003C200], [@cwy003C219]
  **KS--proteoglycans of mucinous tissues**                                                                                                                                                                                                                                                                                                                        
  MUC1                                                                       epithelial distribution                                                                      transmembrane epithelial KSPG, heavily O-glycosylated, sialylated forms 200--500 nm layer on cell surface                                                                                [@cwy003C13], [@cwy003C36]
                                                                             Endometrial ECM                                                                                                                                                                                                                                                                       
  Mucous KSPG                                                                220 kDa 5D4+ve KSPG                                                                          KSPG of cervical mucous secretions                                                                                                                                                       [@cwy003C95]
  Podocalyxcin                                                               240 kDa 3--10 G +ve                                                                          Mucin-like, sialomucin cell surface KS--PG related to CD34. Anti-adhesive. Widespread epithelial distribution                                                                            [@cwy003C226], [@cwy003C328]
  Zona pellucida protein-3 (PZP-3)                                           zona pellucida                                                                               An N-linked polylactosamine sulfated KS protein with oocyte--sperm receptor interactive activity                                                                                         [@cwy003C220], [@cwy003C230]
                                                                             Oocyte membrane glycoprotein                                                                                                                                                                                                                                                          
  Keratinocyte perlecan                                                      Epidermis                                                                                    Hybrid KS-HS-CS basement membrane proteoglycan with roles in ECM stabilization and growth factor binding                                                                                 [@cwy003C170]
  Embryoglycan                                                               Cell surface PG of Pluripotent and early embryonic stem cells                                Highly branched polylactosamine non-sulfated KS chains contain 3-G10, EMCA-2, 3, TRA-1-60 and TRA-1-81, GCTM-2, SSEA carbohydrate motifs                                                 [@cwy003C79], [@cwy003C216], [@cwy003C244]
  **KS--proteoglycans of the PNS/CNS**                                                                                                                                                                                                                                                                                                                             
  Abakan                                                                     Astrocyte KSPG, co-distributed with glial fibrillary acidic protein                          Provides repulsive axonal guidance cues which regulate neuritogenesis in CNS development                                                                                                 [@cwy003C119]
  Claustrin/MAP1B                                                            Claustrin, ECM PG synthesized by CNS astrocytes. MAP1B is a microtubule associated protein   Claustrin, anti-adhesive neural proteoglycan inhibits neurite outgrowth, N-terminal truncated MAP-1B, a 225 kDa microtubule and dendritic PG of neurons and glial cells                  [@cwy003C44], [@cwy003C82]
  Synapse vesicle protein 2 (SV2)                                            12 span membrane KSPG, 100/250 kDa forms and 3 isoforms SV2A, B, C                           Storage/neurotransmitter transport in synaptic vesicles/neuroendocrine cells. KS of SV2 interactive component of a smart gel delivery system                                             [@cwy003C16], [@cwy003C89], [@cwy003C282]
  PG1000                                                                     KS/CS proteoglycan Electric organ ECM                                                        Forms 2--6 monomer complexes concentrated in the reticular laminae of electric organ basement membranes surrounding nerve fibers/terminals                                               [@cwy003C51], [@cwy003C155]
  Phosphacan, RPTP-β/PTPζ, (DSD-1 in mice)                                   PNS, CNS KSPG also has CS and HNK-1 substitution. Phosphacan is the ecto-domain of PTPζ      PTPζ is a type I transmembrane glycoprotein, carbonic anhydrase motif interacts with pleiotrophin and midkine to promote neurite outgrowth activity                                      [@cwy003C88], [@cwy003C118], [@cwy003C214]
  **Miscellaneous KS-substituted proteins**                                                                                                                                                                                                                                                                                                                        
  Transferrin, thyroglobulin                                                 Associated with papillary thyroid carcinoma                                                  KS epitope is capped with α2-3 *N*-acetylneuraminic acid                                                                                                                                 [@cwy003C197]
  Cytokeratin                                                                epidermal protein                                                                            Human keratinocytes contain keratin filaments containing KS chains                                                                                                                       [@cwy003C275]
  Prostaglandin-D synthase                                                   28 kDa KS-glycoprotein produced by bovine corneal keratocytes                                Corneal retinoid transporter, also found in seminal plasma, rat brain and spinal cord, rat cochlea, human prostate, human and rat epididymis and testes                                  [@cwy003C27]
  Mammallin                                                                  Avian KS proteoglycan                                                                        Role in egg shell production, binds Ca2+ and maintains a Calcium reserve. Mammallin awaits full characterization. The KS content of egg shells correlates directly with their strength   [@cwy003C77], [@cwy003C127]

CNS, central nervous system; SV2, synaptic vesicle protein 2; RPTPβ, receptor protein tyrosine phosphatase β; PTP ζ, protein tyrosine phosphatase ζ.

Biosynthesis of KS {#cwy003s8}
------------------

KS biosynthesis involves the sequential action of the β-1,3-*N*-acetylglucosaminyltransferase (β3GnT), *N*-acetylglucosaminyl-6-sulfotransferase (GlcNAc6ST), β1,4-galactosyl transferase (β4GalT-1) and KS galactosyl sulphotransferase (KSGalST) biosynthetic enzymes. KS-I and II differ from other GAGs in that their biosynthesis is initiated through an N-linkage between GlcNAc and asparagine ([@cwy003C285]; [@cwy003C58]; [@cwy003C252]), or *O*- linkage between GalNAc and serine/threonine, in KS-II ([@cwy003C35]; [@cwy003C58]; [@cwy003C167]). Biosynthesis of KS-I begins in the ER where dolichol phosphate on the ER membrane acts as a glycosyl receptor for the formation of high mannose N-linked oligosaccharide. The complex is then transferred to the Golgi apparatus where an GlcNAc residue is added and this is sulfated by GlcNAc6ST. The substrate donor molecule 3′-phosphoadenosine 5′-phosphosulphate (PAPS) is also required for sulfation to proceed ([@cwy003C78]; [@cwy003C2]; [@cwy003C176]). If addition of GlcNAc does not occur, the N-linked mannose may be converted to a complex N-linked oligosaccharide ([@cwy003C132]; [@cwy003C78]). In contrast, the biosynthesis of the KS-II linkage region and attachment of GlcNAc does not begin until the proteoglycan protein precursor reaches the Golgi apparatus ([@cwy003C132]). As with KS-I, chain elongation depends on the expression of glycosyltransferase and sulphotransferases and the availability of UDP-sugar precursors to alternately add GlcNAc then Gal residues to the KS poly-*N*-acetyllactosamine backbone then some of these residues are selected for sulfation at C6.

### Galactosyltransferases {#cwy003s9}

Glycosyltransferases are responsible for the sequential addition of Gal and GlcNAc to the growing KS chain ([@cwy003C106]). Several families of galactosyltransferases (Gal-T) have been identified ([@cwy003C8]). β4GalT-1 catalyzes the addition of UDP-Gal to a non-reducing terminal GlcNAc acceptor, via a β1--4 glycosidic linkage generating the non-sulfated poly-*N*-acetyllactosamine domains which comprise the basic unit of the KS molecule ([@cwy003C37]; [@cwy003C276]). Another galactosyl transferase, β4 GalT-4, is the only galactosyl transferase which catalyzes transfer of Gal to a non-reducing terminal GlcNAc-6-sulfate acceptor residue ([@cwy003C283]) and is essential for the production of mono- and disulfated disaccharides in the KS chain. β4 GalT-4 is also the only GalT enzyme which generates the initial branch points found in the 2 *O*-linked poly-*N*-acetyllactosamine regions of the KS core structure.

### *N*-Acetylglucosaminyltransferases {#cwy003s10}

Seven β3 *N*-acetyl glucoaminyltransferases (β3GnT-1, 2, 3, 4, 5, 6, 7) can catalyze the addition of GlcNAc via β3 linkage to non-reducing terminal Gal or GalNAc ([@cwy003C284]). One of these enzymes acts most efficiently in the elongation of the linear poly-*N*-acetyllactosamine region known as the "i" antigen and is designated iGnT and has a broad tissue distribution.

### Sulphotransferases {#cwy003s11}

Sulphotransferase enzymes transfer sulfate groups from the PAPS donor to C6 of Gal or GlcNAc in KS. Gal-6-sulphotransferase (KSGal6ST) transfers sulfate groups to C6 of Gal and GlcNAc-6-sulphotransferase (GlcNAc6ST) transfers sulfate to the C6 of GlcNAc. Sulfation of Gal is normally incomplete in corneal KS but occurs at a higher level in skeletal KS whereas sulfation of GlcNAc residues is nearly complete. Chondroitin sulfate sulphotransferase (C6ST) catalyzes the addition of a sulfate group to GalNAc in CS, but also to Gal in cartilage and corneal KS ([@cwy003C128]). Five GlcNAc-6-sulphotransferase genes have been identified ([@cwy003C283]). GlcNAc6ST-5 sulfates the non-reducing terminal GlcNAc in both human ([@cwy003C2]) and mouse tissues ([@cwy003C322]). KSGal6ST catalyzes the addition of sulfate to an internal Gal residue within the KS chain ([@cwy003C105]). Sulfation of Gal in unsulfated KS disaccharides is much lower than in disaccharides where GlcNAc is already sulfated, indicating that GlcNAc sulfation precedes and may be a prerequisite for Gal sulfation during the biosynthesis of KS. This also explains why it is only the GlcNAc of the KS disaccharide unit which is sulfated in regions of monosulfation along the KS chain.

### KS Synthesis and Corneal Development {#cwy003s12}

The cornea is the richest source of KS in the human body. Corneal KS is N-linked to one of three proteoglycan core proteins, lumican, keratocan or mimecan (Table [I](#cwy003TB2){ref-type="table"}). The cornea is a tissue which is composed of \~90% stroma and is covered anteriorly with epithelium and posteriorly with endothelium. The cornea is a curved transparent tissue that focuses light into the eye. The remarkable transparency and optical clarity of the cornea results from the strict regularity of the orthogonal distribution of collagen fibers of uniform diameter and interfibrillar spacing in this tissue. Four SLRPs in the cornea, decorin, lumican, mimecan and keratocan critically regulate collagen fibril size and interfibrillar spacing essential for the correct functional properties of this tissue. KS synthesis in the cornea starts at early stages of fetal development, and progressive developmental changes occur in KS antigenic determinants in specific regions of the cornea and conjunctiva over time. [@cwy003C305] raised 25 monoclonal antibodies to KS-I, and one clone to KS-II \[J14\] to examine the distribution of KS epitopes in lapine corneal development. The specific epitopes identified by each antibody clone were not reported however differences were evident in the spatio-temporal distribution of KS epitopes in the developmental rabbit cornea and conjunctival stroma over time and an apparent lack of KS in early stages of rabbit corneal development. However, this was a methodological deficiency since KS antibodies such as 5-D-4 detect highly sulfated KS epitopes only. Low sulfation KS would not have been detected. Since MAb 1-B-4 ([@cwy003C202]) and MAb R-10G ([@cwy003C161]; [@cwy003C221]) which detect these were not used in this study.

### The Sulfation Status of KS Chains as Regulatory Motifs in Tissue Morphogenesis {#cwy003s13}

Chick corneal KS is initially synthesized in E5--E7 as a non-sulfated poly-*N*-acetyllactosamine form, sulfation occurs over E12--E18 to form KS ensuring correct spacing of collagen fibrils essential for optical clarity, this also fine-tunes corneal hydration as the stroma undergoes compaction during development ([@cwy003C32]; [@cwy003C187]). Many antibodies have been raised to KS, the majority of these detect highly sulfated determinants on KS (Table [II](#cwy003TB1){ref-type="table"}). A few antibodies have also been raised which specifically detect low sulfation and non-sulfated epitopes in poly-*N*-acetyllactosamine located on the embryonic cell surface ([@cwy003C9]; [@cwy003C250]; [@cwy003C1]; [@cwy003C161]). These antibodies were originally developed to identify pluripotent embryonic stem cells and human induced pluripotent cells ([@cwy003C1]) to differentiate these from embryonic carcinoma stem cell populations which contain highly sulfated KS ([@cwy003C243]; [@cwy003C244]; [@cwy003C217]). KS is synthesized by the chick cornea between E5 and E7, but only becomes highly sulfated by E14 ([@cwy003C131]) with a switch in KS biosynthesis from an unsulfated form to sulfated KS between E12 and E15 ([@cwy003C62]). The low sulfation form of KS in early corneal development displays antigenic determinants in the poly-*N*-acetyllactosamine chain identified by EMCA-2, EMCA-3, TRA-1-60/TRA-1-81 and R-10G ([@cwy003C161]; [@cwy003C221]). Human auto-antibodies to the blood group substances i- and I-antigen also identify determinants in embryonic KS chains ([@cwy003C187]). These epitopes are masked by the sulfated KS epitopes in mature tissues ([@cwy003C315]). The glycosylation status of cell surface KS is an important regulatory determinant in tissue development ([@cwy003C233]). Antibodies which detect highly sulfated KS on the cell surface of tumor cell proteoglycans such as podocalyxcin have found application as diagnostic biomarkers.

KS and human disease {#cwy003s14}
--------------------

### KS in Macular Degeneration {#cwy003s15}

Macular dystrophy is a relatively rare eye condition linked to inherited genetic mutations. Macular dystrophy causes deterioration of the most sensitive part of the central retina (macula), which has the highest concentration of light-sensitive cells (photoreceptors). Alterations in the degree of sulfation of KS through mutations in the *CHST6* gene result in corneal opacity in macular corneal dystrophy in humans ([@cwy003C84]; [@cwy003C110]; [@cwy003C86], [@cwy003C85]; [@cwy003C193]; [@cwy003C68]; [@cwy003C304]; [@cwy003C247]).

### KS in Cornea Plana Type 2 and Keratoconus {#cwy003s16}

Mutations in the KERA gene cause the disorder cornea plana type 2 (CNA2) ([@cwy003C192]; [@cwy003C263]; [@cwy003C175]). In patients with CNA2 the cornea lacks the normal convex profile which prevents the correct refraction of light through the lens. Defective KS chain elongation occurs in keratoconus ([@cwy003C112]; [@cwy003C4]; [@cwy003C115]). Keratoconus is a disorder of the eye which results in progressive thinning of the cornea leading to blurry vision, double-vision, near-sightedness, astigmatism and light sensitivity ([@cwy003C112]; [@cwy003C83]; [@cwy003C87]; [@cwy003C262]). To ascertain the importance of KS sulfation on KS functionality, mice with a targeted gene deletion in Chst5 have been developed ([@cwy003C133]). Chst5 encodes an *N*-acetylglucosamine-6-*O*-sulfotransferase that is integral to the sulfation of corneal KS chains. Corneas of homozygous mutants were significantly thinner than those of WT or heterozygous mice and lacked high-sulfated KS, but contained the core protein of the major corneal KSPG, lumican. The corneal stroma of the Chst5-null mouse exhibited widespread structural alterations in collagen fibrillar architecture, decreased interfibrillar spacing and spatially disorganized collagen arrays indicating that the KS sulfation had important roles to play in collagen matrix organization ([@cwy003C133]).

### Aberrant KS Biosynthesis in Amyotrophic Lateral Sclerosis {#cwy003s17}

ALS (Lou Gehrig's disease), or amyotrophic lateral sclerosis, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord.

KS chains have essential roles to play in ALS, a motor neuron disease which rapidly targets motor neurons and is a progressive, fatal neurological condition affecting voluntary muscle control ([@cwy003C138]; [@cwy003C102]). Motor neurons are located in the brain, brain stem, and spinal cord and are vital lines of communication between the nervous system and voluntary muscle groups. Progressive motor neuronal death results in muscle weakening, atrophy and eventually a complete inability to control voluntary muscular movement. Respiratory failure is a common cause of death in ALS patients ([@cwy003C138]). Nonsense and missense mutations in the CHST6 gene for Carbohydrate sulphotransferase 6 cause ALS. The *CHST6* gene product, corneal *N*-acetylglucosamine-6-sulfotransferase (C-GlcNac6ST), is important for the production of sulfated KS. Lack of activity of this enzyme results in the production of unsulfated KS, leading to a loss of transparency in the corneas of affected patients ([@cwy003C84]; [@cwy003C3]; [@cwy003C86], [@cwy003C85]; [@cwy003C149]; [@cwy003C6]; [@cwy003C247]).

### The Role of KS in Mouse Models of COPD {#cwy003s18}

A KS disaccharide (\[SO~3~^−^-6\]Galβ1--4\[SO~3~^−^-6\]GlcNAc) has been examined as a therapeutic agent in a murine model of elastase-induced-emphysema and in an LPS-induced exacerbation model of cigarette smoke-induced emphysema ([@cwy003C114]). The KS--disaccharide treatment attenuated alveolar destruction, resulted in a reduced neutrophil influx and a reduced levels of inflammatory cytokines and MMPs in lung tissues resulting in reduced inflammation and lung tissue destruction. KS disaccharide also blocked the chemotactic migration of neutrophils in vitro and was as effective as dexamethasone in preventing the accumulation of inflammatory neutrophils in lung tissues in vivo. Thus KS-disaccharide displayed potential as an agent for the treatment of chronic obstructive pulmonary disease (COPD) deserving further evaluation.

### Alzheimers Disease {#cwy003s19}

Aberrant sulfation levels of KS are found in the brains of Alzheimers patients ([@cwy003C354]).

The interactivity of KS with neuroregulatory effector proteins, nerve growth factor and receptor proteins, synaptic proteins, neurotransmitters and cytoskeletal components ([@cwy003C60]) suggests likely effects which may explain the impact on cognitive learning and memory associated with Alzheimers disease ([@cwy003C191]; [@cwy003C295]).

KS antibodies and their use in the elucidation of KS structural complexity {#cwy003s20}
--------------------------------------------------------------------------

The first antibody identified that specifically recognized a native "GAG structure-specific epitope" was 5-D-4 ([@cwy003C52]). Interestingly, of all four classes of GAGs, KS has the largest number of antibodies which have been developed to various KS antigenic epitopes lending tacit support to the importance of emerging roles for KS in the pathobiology of connective tissues (Table [II](#cwy003TB1){ref-type="table"}). The range of antigenic determinants detected using these antibodies testifies to the structural complexity and biodiversity of KS. GAGs are information dense molecules which provide molecular recognition and directive information to cells influencing cellular behavior in tissue development, tissue morphogenesis and the maintenance of tissue homeostasis ([@cwy003C203]).

EMCA is detected in early embryonic stem cells and pluripotent stem cells particularly in the intestinal epithelium which is covered by a continuous layer of mucus ([@cwy003C43]). MUC-1 in the glandular endometrial endothelium carries small sulfated KS chains identified by MAb 5D4 and the anti-sialo KS antibody D9B1 ([@cwy003C13]). These KS chains are believed to influence the adhesive/anti-adhesive properties of MUC1 and may have roles in the spatio-temporal regulation of embryo implantation ([@cwy003C293]; [@cwy003C139]; [@cwy003C11]; [@cwy003C123]; [@cwy003C13]). Endometrial MUC1 also bears sialyl Lewis X epitope which has roles in selectin-mediated cell adhesion and tissue morphogenesis.

GCTM-2 is an epitope on the core protein of a mucin-like KS/CS pericellular matrix PG, podocalyxcin expressed by human pluripotent stem cells ([@cwy003C249]). MAb TRA-1-60 and TRA-1-81 also recognize epitopes on carbohydrate side chains on the same molecule ([@cwy003C221]). A related diagnostic MAb to EMCA detects serum epitheliamucin epitopes arising from breast cancer tumors ([@cwy003C74]). EMCA is also a carbohydrate component of embryoglycan, a branched poly-[d]{.smallcaps}-*N*-acetyllactosamine mucin-like cell surface glycan expressed by embryonic cells. TRA-1-60 and TRA-1-81 antigens are commonly used as markers of undifferentiated pluripotent human stem cells ([@cwy003C278]). Glycan array analysis of more than 500 oligosaccharides has identified the TRA-1-60 and TRA-1-81 epitopes as terminal type 1 lactosamine: Galβ1--3GlcNAcβ1--3Galβ1--4GlcNAc and Galβ1--3GlcNAcβ1--3Galβ1--4GlcNAcβ1--6(Galβ1--3GlcNAcβ1--3)Galβ1--4Glc. Effective antibody binding requires an extended tetrasaccharide structure where the type 1 disaccharide is β1,3-linked to type 2 lactosamine ([@cwy003C222]). The TRA-1-81 epitope is resistant to neuraminidase digestion, unlike the TRA-1-60 epitope. The "TRA" antigen is named after "The battle of Trafalgar"; however, some authors also refer to this as tumor rejection antigen ([@cwy003C278]).

The TRA-1-60 and TRA-1-81 and GCTM-2 epitopes on KS are unique to primate pluripotent stem cells ([@cwy003C249]; [@cwy003C1]). These epitopes are sensitive to endo-β-[d]{.smallcaps}-galactosidase, keratanase-I, keratanase II and *N*-glycanase digestion and are completely lost upon differentiation of the stem cells. Podocalyxcin, a cell surface mucin-like stem cell KSPG bears the TRA-1-60, TRA-1-81 KS epitopes ([@cwy003C9]; [@cwy003C221]). Antibody R-10G also identifies low sulfation KS chains on podocalyxcin ([@cwy003C61]) in induced pluripotent stem cells and embryonic stem cells distinguishing these from embryonal carcinoma cells expressing podocalyxcin containing oversulfated KS chains detected using MAb 5-D-4. Another antibody to oversulfated KS (MAb 4-C-4) also detects cell surface KS on embryonic carcinoma cells ([@cwy003C104]). Thus podocalyxcin apparently follows a similar developmental pathway to corneal KSPGs. Corneal KS is initially synthesized in the chick embryo as a non-sulfated chain in which the polylactosamine i-antigen can be detected ([@cwy003C187]), with development the i-antigen becomes obscured through branching to form the I antigenic structure. Sulfation of the polylactosamine chain with tissue maturation produces oversulfated KS obscuring detection of the "i" epitope. The "i" (Galβ1--4GlcNAcβ1--3Galβ1--4GlcNAcβ1--3Gal-) and branched "I" antigens (Figure [2](#cwy003F2){ref-type="fig"}) are recognized by human cold reactive monoclonal IgM auto-antibodies ([@cwy003C90]).

A related bi-, tri- or higher antennary branched 120--440 kDa proteoglycan composed of a complex core polylactosamine assembled from β1--3-linked [d]{.smallcaps}-GlcNAc and [d]{.smallcaps}-Gal units has also been observed on embryonic cells ([@cwy003C79]; [@cwy003C216]). Embryoglycan carries a number of developmentally regulated glycan marker molecules such as the trisaccharide Gal(β1→4)-\[Fuc(α1→3)\] GlcNAc Lewis X epitope, also known as CD15/SSEA-1 (stage-specific embryonic antigen) ([@cwy003C298]), a cell surface marker of embryonic stem cells, embryonal carcinoma cells and multipotential cells of early embryos ([@cwy003C217]). These glycans mediate cell adhesion in pre-implantation embryos, aggregation of endothelial cells ([@cwy003C172]; [@cwy003C34]) and cell--cell interaction of galactosyl transferase and *N*-acetylglucosamine in polylactosaminoglycans. Lewis X acts as a recognition molecule for FGF-2 and plays an active role in the formation of ligand--receptor complexes ([@cwy003C79]). Lectin studies employing *Helix pomatia* agglutinin, soybean agglutinin, *Sophora japonica* agglutinin, *Ricinus communis* agglutinin-1, *Griffonia simplicifolia* agglutinin-I, *Dolichos biflorus* agglutinin and peanut agglutinin identify *N*-acetylgalactosamine, *N*-acetylglucosamine and/or galactose as components of the side chains of embryoglycan ([@cwy003C243]). Embryoglycan contains variable levels of sialylation and fucosylation (Figure [5](#cwy003F5){ref-type="fig"}). The ectodomains of embryoglycan regulate FGF-2 activity ([@cwy003C79]). Normal embryonic stem cells also synthesize low sulfation KS detected by MAb R-10G ([@cwy003C161]; [@cwy003C221]).

*Antibody SSEA-1 detects stage-specific embryonic antigen-1* (CD15/Lewis X/3-fucosyl-*N*-acetyllactosamine) on cell surface glycoproteins, glycolipids and PGs on murine pluripotent stem cells and embryos at the pre-implantation stage. SSEA-1 is also expressed as a developmental marker in *Xenopus laevis* in early stage embryos but appears as a 200 kDa glycoprotein in later stage embryos facilitating cell--cell adhesion and interactions which promote tissue morphogenesis through the selectin cell adhesion glycoprotein family ([@cwy003C346]). Multipotent haematopoietic stem cells expressing the SSEA-1 epitope populate skin wounds and actively promote skin healing ([@cwy003C217]; [@cwy003C186]).

MAbs 5-D-4, 1-B-4 and MZ-15 are highly specific for sulfated poly-*N*-acetyllactosamine sequences found in KS but not non-sulfated poly-*N*-acetyllactosamine sequences of I- and i-antigen ([@cwy003C202]). The minimum size of KS oligosaccharide detected by KS antibodies 5-D-4, 1-B-4 and MZ-15 is a linear heptasulfated hexasaccharide, although 1-B-4 also reacts with a tetrasulfated analog ([@cwy003C202]). MZ-15 reacts with hepta and octa-saccharide KS oligosaccharides. Antibody 5-D-4 differs from the 1-B-4 and MZ-15 antibodies in that it reacts strongly with a hexa sulfated octa-saccharide, and most strongly with a linear dodecasaccharide which may contain *N*-sulfated glucosamine residues ([@cwy003C202]). A sialo-KS epitope in sulfated KS is also recognized by Mab D9B1 ([@cwy003C13]). MAb 4-C-4 detects a sialyl fucosyl-KS proteoglycan containing highly sulfated KS on embryonic carcinoma cells ([@cwy003C104]). Monoclonal antibody, 6D2/B5, recognizes a fucosyl-KS epitope in cartilage proteoglycans and also detects fucoidan ([@cwy003C18]). A novel anti-KS antibody 3D12/H7 identifies KS chains interspersed within the CS rich region of the aggrecan core protein in articular cartilage and to a significantly lesser extent in tracheal cartilage aggrecan and corneal extracts ([@cwy003C94]). MAb 3D12/H7 does not identify the KS chains from the KS-rich region on aggrecan. The 3D12/H7 KS antibody does not recognize fragmented KS species released by keratanase I/keratanase II digestion of the intact KS chains. It does, however, identify intact KS chains from the CS-rich region of aggrecan isolated by chondroitinase ABC and papain digestion. The specific KS epitope identified by 3D12/H7 is within the oligosaccharide linkage region of the KS chain which contains three sulfate groups and two fucose residues on the GlcNAc residues in this region of the KS chain. These KS chains are preferentially expressed within the CS-rich region on the aggrecan core protein ([@cwy003C94]).

Further KS antibodies have been developed to a moderately sulfated (MAb 4-D-1) and a highly sulfated epitope in linear poly-*N*-acetyllactosamine (MAb 2-D-3); however, these still require detailed characterization (B. Kerr PhD Thesis, University of Cardiff, University of Cardiff, 2005). A number of KS antibodies identify tri-KS disaccharides (BVD-4, EFG-11) or ill-defined highly sulfated KS epitopes (122, LC8.13, F1.2) (Table [II](#cwy003TB1){ref-type="table"}). MAb F1.2 is claimed to identify a conformation dependant KS epitope on the aggrecan core protein but not in small KS-peptides.

Variation in GAG chains on cell-associated and tissue KSPGs {#cwy003s21}
-----------------------------------------------------------

In common with other PGs, KSPGs are important ECM and cell-associated components which provide hydration, stabilization and organization, and facilitate cell adhesion, cell migration and proliferation, neurotransmitter processing, synaptic function and neurotransmission. KSPGs and their GAG side chains act as a cell recognition and information biosensor system which regulates cellular behavior ([@cwy003C203]). The information contained within the sulfated sugars and poly-*N-*acetyllactosamine residues of KS regulate growth factor and morphogen binding and through interactions with FGF, IGFBP2, Wnt, Shh and BMPs they regulate essential physiological and developmental processes ([@cwy003C269]; [@cwy003C337]). The interaction of KS with IGFBP2 may be significant. The Cdk4 pathway is operative in neuritogenesis and is activated by insulin. This induces neural cell proliferation and terminal differentiation ([@cwy003C57]). Microarray studies with corneal KS demonstrate that it also interacts with the Ephrin 4 receptor and may promote neuronal cell proliferation and differentiation through Ephrin tyrosine kinase activity ([@cwy003C194]).

### Podocalyxcin {#cwy003s22}

Podocalyxcin is a cell surface mucin-like 250 kDa sialo KSPG expressed by stem cells which is also associated with pluripotency and bears the TRA-1-60 and TRA-1-81 KS epitopes ([@cwy003C9]). GCTM-2 Ab also identifies 240 and 415 kDa KSPGs on the surface of embryonal carcinoma cells ([@cwy003C250]). A novel antibody to KS (R-10G) does not identify oversulfated KS ([@cwy003C161]) but identifies low sulfation KS chains on podocalyxcin ([@cwy003C61]). Thus podocalyxcin follows a similar developmental pathway to corneal KSPGs. Corneal KS is initially synthesized in the chick embryo as a non-sulfated chain in which the polylactosamine i-antigen can be detected ([@cwy003C187]). As embryonic development ensues the i-antigen becomes obscured due to branching to in the I-antigenic structure and progressive sulfation of components of the poly-*N*-acetyllactosamine epitopes occurs with tissue maturation leading to an accumulation of highly sulfated KS. Normal embryonic stem cells synthesize low sulfation KS chains detected by MAb R-10G ([@cwy003C161]; [@cwy003C221]). This is carried by the cell surface mucin-like KS--proteoglycan podocalyxcin. Embryonal carcinoma cells or mature human tissues also express podocalyxcin but it contains an oversulfated form of KS, the sulfation status of podocalyxcin correlates with the invasiveness, metastatic and growth potential of tumor cells ([@cwy003C188], [@cwy003C189]). The sulfation motifs on KS represent an important molecular switch which regulates cellular behavior. When this occurs in an appropriate ordered fashion the tissue progresses from an embryonic phenotype containing low sulfation KS to a normal functional adult tissue containing highly sulfated KS. When this process is dysregulated with the occurrence of early oversulfated KS in embryonic tissues tumor development occurs. The form of lumican expressed by tumor cells also bears oversulfated KS and correlates with the metastatic potential of these cells ([@cwy003C196]; [@cwy003C218]; [@cwy003C143]; [@cwy003C288]; [@cwy003C153]; [@cwy003C201]; [@cwy003C38]; [@cwy003C65]; [@cwy003C229]; [@cwy003C47]).

### Organization of KS Saccharides Effect the Functional Properties of Intact KS Chains {#cwy003s23}

As noted earlier, three types of KS chains have been categorized on the basis of linkage type to PG core proteins, internal saccharide organization and the presence or absence of internal or non-reducing terminal α1-3 fucose or α2,3 neuraminic acid capping saccharides. A number of monoclonal antibodies have been developed which identify the sulfation status of the KS chains. MAbs such as 5-D-4, MZ-15, EFG-4, EFG-11, 122, SV-1, SV-2, SV-4, 3D12/H7 and 4-C-4 detect highly sulfated KS sulfation epitopes (Table [II](#cwy003TB1){ref-type="table"}). MAb 1-B-4, 2-D-1, 2-D-3, LC8.13 and R-10G detect lower sulfation KS sulfation epitopes. MAbs to non-sulfated epitopes within the poly-*N*-acetyllactosamine regions of KS chains including anti "i" (Tho), anti-I (Den) antigens have also been identified. A KS neoepitope antibody to KS has also been developed, BKS-1(+) ([@cwy003C5]). This antibody detects a keratanase-generated "stub epitope" on the KS chains. The susceptibility of the KS chains to degradation by depolymerizing enzymes such as keratanase-I, keratanase-II and endo-β-[d]{.smallcaps}-glycosidase (Figure [2](#cwy003F2){ref-type="fig"}) have been used to confirm the sulfation status of the KS chains and undertake their structural characterization, GAG sequencing and estimations of GAG chain size.

### KSPGs Associated with Oocyte Implantation and Fertilization {#cwy003s24}

The KS content of endometrial uterine lining tissues varies markedly during the menstrual cycle, reaching a peak at the time of embryo implantation ([@cwy003C123]). KS substitution on MUC1 and other PGs in the endometrial lining suggests a potential role for KS in this implantation process. A number of large KSPGs have been identified in endometrial tissue ([@cwy003C72]) with roles in tissue organization and in uterine mucous secretions however the fine structure of their KS chains have not been determined. PZP-3 is one such KS-substituted protein containing low sulfation N-linked lactosamine residues with roles in the promotion of oocyte--sperm interactions which regulate fertilization ([@cwy003C230]; [@cwy003C344]; [@cwy003C126]; [@cwy003C220]).

### Variation in the Sulfation of KS Chains of Other Proteoglycans in Normal Tissues {#cwy003s25}

Fibromodulin from young articular cartilage, contains KS chains ([@cwy003C183]) devoid of non-reducing terminal (α2--6)-linked *N*-acetylneuraminic acid or fucose (α1--3)-linked to sulfated *N*-acetylglucosamine residues ([@cwy003C184]). An age-related increase in the abundance of both (α2--6)-linked *N*-acetylneuraminic acid and (α1--3)-linked fucose occurs on the KS chains of fibromodulin in articular cartilage. KS isolated from non-articular tissues does not contain these capping structures irrespective of tissue age.

PRELP is a further "non-GAG" member of the SLRP family containing low sulfation KS chains. PRELP contains four potential N-linked glycosylation core protein sites as are present in the related KSPGs lumican and fibromodulin. Shorter low sulfation KS chains may however be present in PRELP. A study in 1995 by Bengtsson and colleagues showed that keratanase digestion of PRELP produced a small size shift on SDS-PAGE, suggesting the presence of either small KS chains or non-sulfated poly-*N*-acetylactosamine. Attempts to identify KS chains on the intact protein and on peptide fragments using several monoclonal KS antibodies, however, were inconclusive but it was not reported whether antibodies capable of detecting low sulfation KS epitopes were employed ([@cwy003C25]). PRELP has also been identified as a component of the cornea and sclera where it was present as a 60--116 and 55--60 kDa protein, respectively. Digestion with endo-β-[d]{.smallcaps}-galactosidase converted the corneal PRELP to 45--50 kDa in size and the scleral PRELP to a protein with a molecular weight of 50 kDa ([@cwy003C156]). Digestion with *N*-glycanase resulted in a further reduction in size to 42--45 and 45KDa in the corneal and scleral PRELP samples demonstrating N-linked KS chains of low sulfation. Keratanase-I and II were ineffective in depolymerizing the PRELP KS chains confirming that they were not highly sulfated. Thus PRELP can occur as a KS-substituted glycoprotein in these tissues and contains small low sulfated KS chains ([@cwy003C156]).

### Variation in Highly Sulfated KS Levels in Connective Tissues with Ageing {#cwy003s26}

Although there is a generalized decline in connective tissue GAG levels with ageing, the relative KS content of these tissues increases with tissue maturation particularly in tissues subjected to high compressive load such as the IVD ([@cwy003C236], [@cwy003C237]; [@cwy003C281]). Highly sulfated KS is absent in the fetal IVD, detectable in the newborn and its levels progressively increase with the maturation of the IVD ([@cwy003C206], [@cwy003C207]). Fibromodulin was more abundant in the AF than in NP at all ages, its levels were elevated in the adult NP ([@cwy003C307]). With increasing age, the glycoprotein form of fibromodulin lacking KS was the predominant molecular form present in IVD tissues. The abundance of fibromodulin increases with disc degeneration ([@cwy003C307]). Lumican is more abundant in the NP than AF juvenile IVD; however, in the adult it was present at comparable levels in both tissues.

### KS Structure and Function in Aggrecan {#cwy003s27}

Aggrecan is a major KS--proteoglycan which equips tissues with the ability to resist compression. KS substitution in aggrecan occurs at several locations (i) individual small *N*- and *O*-linked KS chains are attached to the N-terminal G1 and G2 domains, (ii) small *N*- and *O*-linked KS chains are also located in the IGD between G1 and G2, (iii) a KS-rich region is located between the G2 and CS1 domains which contains *O*-linked KS chains and (iv) occasional isolated single or doublet KS chains also occur in the CS1 and CS2 domains of aggrecan (Figure [3](#cwy003F3){ref-type="fig"}G).

### KS Chains in the G1 Domain Inhibit a T Cell-Mediated Response When Aggrecan G1 is Used as an Arthritogen {#cwy003s28}

A KS side chain in adult aggrecan G1 domain obscures the recognition of arthritogenic T cell epitopes ([@cwy003C185]). A cross-reactive and arthritogenic T cell epitope in the G1 domain of human and murine aggrecan ([@cwy003C121]) elicits an immune response in RA when the KS chains in the G1 domain are absent ([@cwy003C185], [@cwy003C125]). In aggrecan isolated from mature articular cartilage the G1 hyaluronan binding region contains a small KS chain attached to Threonine 42 within loop A. This is not present in the immature G1 domain. A small N-linked KS chain is attached to Asn 220 in the B loop of the G1 domain in immature and mature aggrecan, but in the immature G1 the KS chain is shorter. Asn 314 of the B' loop of mature G1 domain contains KS, however immature G1 does not. The versican G1 domain also contains KS chains; however, these have not been characterized and it is not generally referred to as a KSPG ([@cwy003C308]). The aggrecan G2 domain contains a KS chain located close to the MAb 1-C-6 HABR epitope. This KS chain obscures antibody binding to the 1-C-6 epitope ([@cwy003C98]). The biological significance of this KS chain is un-determined.

### KS Substitution in the Aggrecan IGD Effects MMP and ADAMTS Cleavage {#cwy003s29}

The aggrecan interglobular domain (IGD) can be cleaved by a number of proteinases including aggrecanase-1 and 2 and MMPs ([@cwy003C99]; [@cwy003C179]; [@cwy003C324]; [@cwy003C325]; [@cwy003C54]; [@cwy003C302], [@cwy003C303]). The KS attachment sites in the IGD of porcine and bovine aggrecan are located in a 32 amino acid sequence between the MMP and ADAMTS cleavage sites ([@cwy003C20], [@cwy003C21], [@cwy003C22]). This amino acid sequence is highly conserved and has functional roles in the modulation of aggrecanase-1 and 2 activity ([@cwy003C101]). KS chains are also located in close proximity to the IGD aggrecanase cleavage site ([@cwy003C100]). In cartilage, proteolysis in the IGD releases the entire CS-rich region of aggrecan. Cleavage at E373**↓**374A in the IGD is a signature feature of the aggrecanases but is not actually the preferred cleavage site which is in the CS-2 domain ([@cwy003C319], [@cwy003C320]). ADAMTS-1, ADAMTS-4 and cathepsin B can also cleave at the MMP IGD cleavage site N341**↓**342F ([@cwy003C215]; [@cwy003C261]; [@cwy003C336]).

### Differences in the KS Chains in the KS-Rich Region, IGD and G1, G2 Domains {#cwy003s30}

The GAG chains in the KS-rich region have been extensively studied in human and bovine aggrecan ([@cwy003C309], [@cwy003C310], [@cwy003C311], [@cwy003C73], [@cwy003C40]). However, there is only one study published on the KS microstructure in the IGD ([@cwy003C100]) and a handful of studies on the G1 and G2 KS chains ([@cwy003C22]). The KS chains in the IGD of pig aggrecan are significantly less sulfated than the KS chains from the KS-rich region ([@cwy003C100]). KS in the KS-rich region has a high proportion of disulfated disaccharides (55%) and a low proportion (11%) of unsulfated disaccharides, whereas KS in the IGD has less disulfated disaccharides (33%) and a significantly higher proportion of unsulfated disaccharides (33%) ([@cwy003C100]).

### Species Differences in KS Substitution in Aggrecan {#cwy003s31}

While Swarm rat chondrosarcoma aggrecan contains KS oligosaccharides, these do not undergo elongation and sulfation into mature KS chains. The KS-rich region in rodent aggrecan is spliced out ([@cwy003C232]; [@cwy003C326]) but KS is present in the IGD ([@cwy003C101]) and of low sulfation as seen in pig and rat chondrosarcoma ([@cwy003C232]), and not detected by antibodies to highly sulfated KS epitopes such as 5D4 ([@cwy003C52], [@cwy003C202]) and MZ-15 ([@cwy003C350]).

### Variation in KS Substitution in Aggrecan with Ageing {#cwy003s32}

In humans, the KS content of aggrecan increases from a minimal level at birth to a value of \~25% of the total GAG in adulthood ([@cwy003C40]). The microstructure of KS in the KS-rich region of aggrecan undergoes age-dependant changes ([@cwy003C40]). KS from young articular cartilage (0--9 years) has low sulfation levels compared to KS from adult articular cartilage (18--85 years). Skeletal KS-II in aggrecan isolated from adult articular cartilage is also more highly modified by fucosylation and sialylation than KS from immature tissue. The KS chains of aggrecan from weight-bearing tissues such as articular cartilage and IVD contain 1--3 fucose and 2--6 *N*-acetylneuraminic acid residues ([@cwy003C165]), these are absent in aggrecan isolated from non-weight-bearing nasal and tracheal cartilages ([@cwy003C224]). Increased fucosylation and sialylation of KS confers an increased resistance to depolymerization by keratanase-I and II and endo-β-[d]{.smallcaps}-galactosidase ([@cwy003C205]). KS substitution on aggrecan increases with ageing ([@cwy003C22], [@cwy003C255]) and in the IGD of aggrecan ([@cwy003C22]). The IGD of aggrecan in aged tissues may be more susceptible to proteolysis by aggrecanases ([@cwy003C255]).

Functional roles for KS--proteoglycans in brain tissue {#cwy003s33}
------------------------------------------------------

### Role of the ECM in Brain Tissue Development {#cwy003s34}

The ECM of the brain, a supportive scaffolding network and platform for cellular attachment, is a source of intuitive cues which direct cell behavior. KSPGs also have key functional roles to play in brain tissue (Table [I](#cwy003TB2){ref-type="table"}). The ECM provides cues for the assembly and repair of functional network structures where secreted molecules produced by glial cells and neurons are used to assemble transmitter and effector receptors and ion channels which effect brain function and neuronal control over tissues throughout the human body. Significant inroads have been made on specific molecules which modulate the incorporation of effector molecules into network assemblies in the brain or the shedding of transmembrane activity molecules through proteolytic release of signaling messengers. The ECM is plastic and responsive to such network activity. Dysregulation of the brain ECM is linked to major psychiatric and neurodegenerative diseases.

Proteoglycans play important regulatory roles in the development and function of the brain. Perineural nets are prominent structures formed by interaction of the lectican family of CS--proteoglycans, link protein, hyaluronan and tenascin-R. The perineural nets surround and protect neurons; however, the charge localization provided by the CS-A and CS-C side chains in these assembled structures provides repulsive cues which inhibit neuronal outgrowth in cases of axonal damage. The charge properties of the GAG chains of other brain proteoglycans, however, can promote repair processes and its functional organization. The brain contains several KSPGs (Table [I](#cwy003TB2){ref-type="table"}) including Abakan, PG1000, claustrin, phosphacan and SV-2 with important functional roles to play in the CNS/PNS. In contrast to the CS-A and CS-C chains of the lectican proteoglycan family which inhibit neural repair, the KS chains of phosphacan provide anti-adhesive cues to neuronal cells preventing their interaction with tenascin-C fostering neurite outgrowth following injury and promote axonal repair ([@cwy003C75]).

### Roles for the SLRPs in Neuro-regulation {#cwy003s35}

The SLRP family contains a number of KSPGs which regulate signaling pathways in neural development and in neural maintenance ([@cwy003C71]). A distinguishing feature of the SLRPs is their central LRRs which adopt a horseshoe-like configuration which facilitates protein--protein interactions ([@cwy003C171]; [@cwy003C280]; [@cwy003C150]) and molecular recognition processes, including cell adhesion, signal transduction and DNA repair ([@cwy003C140]; [@cwy003C277]; [@cwy003C334]; [@cwy003C339]) (Figure [3](#cwy003F3){ref-type="fig"}). LRRs are present in more than 6000 proteins ([@cwy003C334]) and approximately 140 genes encode extracellular LRR proteins ([@cwy003C339]). The GAG chains of SLRPs function in the maintenance of the spacing of collagen fibers, normal tissue hydration, and interact with growth factors and their receptors ([@cwy003C171]; [@cwy003C280]; [@cwy003C150]; [@cwy003C277]). Many members of the SLRP family exist without GAG chains and are considered as "part time" proteoglycans but may still have anchoring roles in the ECM due to their LRR containing core proteins ([@cwy003C150]; [@cwy003C140]). The SLRPs also act as matricellular proteins co-ordinating a number of signaling pathways to regulate the development of the neural system through secreted signaling molecules such as Nodal, FGFs, Wnts and Shh ([@cwy003C71]). A number of LRR proteins of the SLRP family have been identified in brain tissues including Tsukushi, decorin, biglycan and fibromodulin ([@cwy003C294]; [@cwy003C301]; [@cwy003C159]; [@cwy003C154]). Cultured meningeal cells and astrocytes synthesize biglycan ([@cwy003C173], [@cwy003C166]). Biglycan stimulates growth of microglial cells ([@cwy003C166]), has neurotrophic activity ([@cwy003C158]) and supports the survival of neocortical neurons ([@cwy003C173]). Decorin is developmentally regulated in postnatal rat brains ([@cwy003C159]). Decorin and biglycan are differentially expressed after injury in the adult rat brain ([@cwy003C301]), decorin has also been immunolocalized in plaques and neurofibrillary tangles in Alzheimers disease ([@cwy003C294]). Fibromodulin has been detected in the hippocampus of a mouse model of Alzheimers disease ([@cwy003C7]). Biglycan and Fibromodulin have both been detected in the hypothalamus and hippocampus in a transcriptomic epigenomic study demonstrating roles for these proteoglycans in gene networks regulating cell metabolism, cell communication, inflammation and neuronal signaling of relevance as genetic causal risks in metabolic, neurological and psychiatric disorders in humans ([@cwy003C208]).

### SV2 Proteoglycan {#cwy003s36}

SV2 proteoglycan has critical neuroregulatory and synaptic regulatory roles via its ability to regulate presynaptic Ca2+ and neurotransmitter levels, malfunctioning of SV2 is implicated in epilepsy ([@cwy003C332]). SV2 is phosphorylated on serine and threonine thus is a substrate for serine/threonine kinases ([@cwy003C257]) which have downline effects on cytoskeletal organization, cell signaling and interactions with neurotransmitters. KS in SV-2 proteoglycan occurs as a large GAG side chain up to 50 Da in size (Figure [4](#cwy003F4){ref-type="fig"}C). SV-2 occurs as 3 isoforms (SV2A, SV2B, SV2C) of variable distribution in the CNS/PNS and as low (100 kDa) and high molecular weight forms (250 kDa). SV-2 has a 80 kDa core protein and contains three N-linked KS substitution sites at amino acids 498, 548 and 573 ([@cwy003C17], [@cwy003C15], [@cwy003C16]; [@cwy003C89]). The KS chains of SV2 interact with neurotransmitters forming a smart gel storage matrix within synaptic vesicles.

### Phosphacan {#cwy003s37}

Phosphacan is the enzymatically released proteoglycan ecto-domain of receptor-type protein tyrosine phosphatase beta (RPTP-β) and is one of the principal ECM proteoglycans of the CNS promoting neuron--glial interactions, neuronal differentiation, myelination and axonal repair (Figure [3](#cwy003F3){ref-type="fig"}B). RPTP-β is expressed in the developing nervous system and contains an extracellular carbonic anhydrase and fibronectin type III repeat domain which foster protein--protein interactions. RPTP is expressed in 3 alternatively spliced forms RPTP-γ, RPTP-β/ζ and a truncated form. The transient nature of cell signaling by phosphorylation requires specific phosphatases in order to control and regulate this process. The complexity of this regulatory system is well illustrated by the many protein tyrosine phosphatases spatially and temporally expressed in specific regions of the developing brain. The carbonic anhydrase (CAH) domain of RPTP-β promotes protein--protein recognition inducing cell adhesion and neurite outgrowth of primary neurons, and differentiation of neuroblastoma cells. Contactin is a neuronal receptor for RPTP-β and its interaction with phosphacan generates unidirectional/bidirectional neural signaling and promotes axonal repair.

### Podocalyxcin {#cwy003s38}

Podocalyxcin is an anti-adhesive transmembrane neural KS-polysialylated-proteoglycan/glycoprotein with essential roles to play in neural development ([@cwy003C329], [@cwy003C328]) and is also a marker of human embryonic and induced pluripotent stem cells ([@cwy003C321]). Podocalyxcin is up-regulated in glioblastomas and astrocytomas ([@cwy003C135]; [@cwy003C321]), leading to its use diagnostically in the detection of various cancers ([@cwy003C226]; [@cwy003C333]) including esophageal and gastric adenocarcinoma ([@cwy003C178]; [@cwy003C33]), colorectal ([@cwy003C181], [@cwy003C180]), breast ([@cwy003C292]; [@cwy003C296]; [@cwy003C124]), hepatocellular ([@cwy003C96]), pancreatic ductal ([@cwy003C136]; [@cwy003C273]), oral squamous cell ([@cwy003C189]), urothelial bladder ([@cwy003C31]), ovarian ([@cwy003C343]), renal ([@cwy003C146]), thyroid carcinoma ([@cwy003C342]) and lymphoblastic and myeloid leukemia ([@cwy003C163]; [@cwy003C259]; [@cwy003C226]). KS chains on podocalyxcin in normal embryonic cells are of low sulfation detected by MAb R-10G ([@cwy003C161]; [@cwy003C221]; [@cwy003C321]) while tumor cells produce a high sulfation KS chain detected by antibodies such as 5-D-4 or MZ-14 ([@cwy003C52]; [@cwy003C270]; [@cwy003C345]). Two cytosolic adapter proteins, Na+/H+-Exchanger Regulatory Factor 2 (NHERF2) and Ezrin, interact with the cytoplasmic tail of podocalyxcin exerting regulatory effects on cell signaling and downline effects on neural behavior during the development and repair of the CNS/PNS. Neural migration and axonal guidance are governed by cues from many ECM molecules (Netrins, Semaphorins) which exert either attractive or repulsive cues. Podocalyxcin is not essential for neural migration to occur but can modulate this process. Cell--cell contact and adhesion to the ECM contribute to neural assembly processes. Adhesion molecules such as NCAM and L1 have important roles to play in axonal growth, neural migration and synapse formation. Podocalyxcin has essential roles to play in neuritogenesis and synaptogenesis ([@cwy003C169]; [@cwy003C81]; [@cwy003C10]). Podocalyxcin co-localizes with synapsin and synaptophysin in synapse vesicle formations ([@cwy003C328]). Synaptophysin is a major synaptic vesicle protein which co-ordinates the endocytosis of synaptic vesicles during neural stimulation ([@cwy003C177]), synapsin tethers synaptic vesicles to cytoskeletal components preventing premature vesicle release into the synaptic gap co-ordinating neurotransmitter release from the synaptic vesicles to communicating neurons ([@cwy003C53]; [@cwy003C97]; [@cwy003C323]; [@cwy003C299]). Podocalyxcin is related to the sialomucins CD34 and endoglycan ([@cwy003C144]; [@cwy003C70]; [@cwy003C164]; [@cwy003C271]; [@cwy003C130]; [@cwy003C213]; [@cwy003C272]; [@cwy003C76]; [@cwy003C225], [@cwy003C226]).

### Abakan {#cwy003s39}

Abakan is a large brain KSPG with at least one CS side chain and one additional carbohydrate chain containing a terminal 3-sulpho-glucuronic acid (HNK-1) ([@cwy003C120]). Abakan is up-regulated during corticol injury in neonatal rats and is associated with astrocytes in the optic nerve and developing brain. At birth, Abakan levels are low in the sensory cortex but its levels steadily increase with tissue maturation reaching maximal levels in the adult brain ([@cwy003C286]). Abakan blocks neural attachment and neurite outgrowth in culture and marks the boundaries of structural regions of the developing brain ([@cwy003C119]; [@cwy003C260]).

Conclusions {#cwy003s40}
===========

KSPGs are a biodiverse multifunctional group of molecules. KS has a widespread distribution in the cornea, cartilage and brain, however, compared to other GAGs relatively little is known of its functional properties (Table [I](#cwy003TB2){ref-type="table"}). KSPGs of widely differing modular design such as aggrecan and fibromodulin occur in hyaline cartilage and fibrocartilage, lumican and keratocan in cornea, SV2 proteoglycan in synaptic vesicles and claustrin, abakan, phosphacan and aggrecan in brain ([@cwy003C152]). One isoform of CD44 (epican) contains KS and the perlecan synthesized by HEK 293 kidney keratinocytes also contains KS. A number of molecules have been demonstrated to contain small low sulfation KS chains (PRELP, transferrin, thyroglobulin, early embryonic KSPGs, podocalyxcin); however, the functional significance of these KS chains is not known. The uniform spacing between collagen fibrils provided by lumican and keratocan in cornea points to their well-established roles in collagen fibrillogenesis, fibril spacing and ECM organization. Roles for brain KSPGs in neurotransmission, synapse organization and nerve regeneration have also been elucidated. Endometrial and uterine KSPGs have roles in implantation and fertilization. Highly sulfated KS chains on a number of cell surface and secreted KSPGs have found diagnostic utility and prognostic capability for the assessment of a number of tumors. KSPGs act as Ca2+ reservoirs in egg shell assembly, bone mineralization and in the generation of action potentials in neurons. SV2 is a transport proteoglycan and forms a smart gel complexes with neurotransmitters within synaptic vesicles. KS is interactive with a large number of protein kinases and nerve associated proteins and new evidence shows KS regulates a number of growth factors, morphogens and inflammatory cytokines in tissue morphogenesis, remodeling and development. It is remarkable that these properties are achieved by a relatively simple GAG. The KS structure is based on the *N*-acetyl-polylactosamine backbone -Galββ(1--4) GlcNAcβ(1--3)-, GlcNAc is normally 6-*O*-sulfated and the Gal disaccharide component can also be 6-*O* sulfated but this varies with tissue location, age and species. α1--3 linked [l]{.smallcaps}-fucose on GlcNAc in the main lactosamine repeat region occurs in articular cartilage but rarely in non-articular tissues (e.g. nasal septum, trachea). Skeletal KSII has two major capping sequences α2--3 and α2--6 linked *N*-acetylneuraminic acid whereas corneal KS has over seven different sugar/linkage combinations involving *N*-acetyl, *N*-glycolyl-neuraminic acids, GalNAc and α-Gal ([@cwy003C338]; [@cwy003C256]). The significance of these capping structures in terms of molecular recognition is not known but they do confer resistance to depolymerization to KS by keratanase-I/II and endo-β-[d]{.smallcaps}-galactosidase.

The identification of a range of molecules with low sulfation small KS chains points to an area of the KS molecule which is poorly investigated. While the charge density of the highly sulfated KS chains is a driving force for many KS-mediated interactions, a high charge density in glycans is not essential for these to impart important recognition and directional cues to cells and the regulation of a number of physiological processes through interactions with lectins and pattern recognition receptors in the human body ([@cwy003C204]). It may well be that such interactions with low sulfation KS chains afford a more subtle level of cellular control than the high charge density mediated interactions provided by oversulfated KS chains such as those detected by MAb 5-D-4. There is still a lot to understand about KS and this area of glycobiology is entering an interesting era.
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ADAMTS, a disintegrin and metalloproteinase with thrombospondin motifs; ALS, amyotrophic lateral sclerosis; BMP, bone morphogenetic protein; BSP-II, bone sialoprotein-II; *β3GnT*, β-1,3-*N*-acetylglucosaminyltransferase; GlcNAc6ST-*1*, *N*-acetylglucosaminyl-6-sulphotransferase, Gn6ST1 (encoded by gene *CHST2*); *β4GalT1*, β1,4-galactosyl transferase1; *β4GalT4*, β1,4-galactosyl transferase4; *KSGalST*, KS galactosyl sulphotransferase; CNS, central nervous system; CXCL1, chemokine (C-X-C motif) ligand 1; ECM, extracellular matrix; EGF, epidermal growth factor; EMCA, embryonic mucin core antigen; FACE, fluorescence assisted carbohydrate electrophoresis; FGF, fibroblast growth factor; Fmod, fibromodulin; GAG, glycosaminoglycan; GCTM-2, human embryonal carcinoma tumor antigen-2; HNK-1, human natural killer antigen-1; IGD, interglobular domain; IGFBP2, insulin-like growth factor binding protein-2; KS, keratan sulfate; KSPGs, keratan sulfate proteoglycans; LRRs, leucine-rich repeats; Lum, lumican; MAb, monoclonal antibody; MMP, matrix metalloprotease; MUC1, cell surface-associated mucin; PRELP, Proline and arginine end leucine-rich repeat protein, Prolargin; PNS, peripheral nervous system; PZP-3, Zona pellucida glycoprotein-3; PGs, proteoglycans; RA, rheumatoid arthritis; RPTP-β, receptor-type protein tyrosine phosphatase beta; SSEA-1, stage-specific embryonic antigen; SV2, synaptic vesicle proteoglycan-2; SLRPs, small leucine-rich repeat proteoglycans; TLR4, Toll-like receptor-4; TGF-β, transforming growth factor-β; TRA 1--60, human embryonal carcinoma marker antigen "TRA"---battle of Trafalgar or tumor rejection antigen; TSP-1, thrombospondin-1
